Lead Plaintiff Deadline is Approaching - Act Now

Applied Therapeutics Inc® Class Action

Alexandru et al v. Applied Therapeutics, Inc. et al.

Applied Therapeutics Inc

NASDAQ: APLT

Class Period : 01/03/2024 - 12/02/2024

Lead Plaintiff Motion Deadline: 2/18/2025

Alleged Misstatements and Omissions
The lawsuit against Applied Therapeutics claims that the company misrepresented critical information about its lead drug candidate, govorestat, during its Phase III INSPIRE trial. Key allegations include:

  • Overstated Efficacy and Confidence: Applied Therapeutics emphasized positive clinical outcomes and confidence in its New Drug Application (NDA) to the FDA and its Marketing Authorization submission to the European Medicines Agency.
  • Concealed Data Issues: The company failed to disclose electronic data capture problems and a dosing error during the dose-escalation phase of the INSPIRE trial, which impacted trial reliability.

These misleading statements painted an overly optimistic picture of govorestat’s progress and potential, causing investors to purchase shares at inflated prices.

Effects on Stock Prices
The truth began to emerge through two key disclosures:

  • November 27, 2024: Applied Therapeutics announced it received a Complete Response Letter (CRL) from the FDA indicating the NDA could not be approved in its current form due to clinical application deficiencies. Following this news, the stock price dropped from $10.21 on November 26 to $8.57 on November 27 and to $2.03 on November 29, a total decline of over 80%.
  • December 2, 2024: After market hours, the company disclosed it received an FDA warning letter highlighting data capture issues and a dosing error. The stock price fell further, from $1.75 on December 2 to $1.29 on December 5.

These revelations caused significant financial losses for shareholders.

Legal Rights for Affected Shareholders
Shareholders who purchased Applied Therapeutics stock during the relevant period may have legal grounds to recover their losses. The lawsuit alleges that Applied Therapeutics violated securities laws by making false and misleading statements about the govorestat trial's progress.

By joining the class action, shareholders can:

  • Seek compensation for financial losses.
  • Hold Applied Therapeutics accountable for alleged misrepresentations.
  • Promote transparency and fairness in the company's disclosures.

You may qualify to participate in the case if you purchased Applied Therapeutics shares and suffered losses.

Take Action Today
Protect your rights and explore your legal options. Contact experienced securities fraud attorneys to ensure your claim is filed before legal deadlines.

Joining the Applied Therapeutics class action allows you to stand with other investors in demanding accountability and seeking fair compensation. Time is critical—act now to safeguard your legal rights.

iStock-1795167728

DiCello Levitt Fights to Protect Shareholder Rights  

At DiCello Levitt, we hold corporations accountable when they betray investor trust. With extensive experience in securities litigation, our legal team has the knowledge and resources to fight for your financial recovery. We understand the impact these losses can have on you and your family.  

Contact us today for a free, private case evaluation. Our attorneys will review your case, help you understand your legal options, and work tirelessly to seek the compensation you deserve. Let us advocate for your rights and ensure your voice is heard.  

Take the first step toward justice. Call us now or fill out our online form to get started.

All victims affected by Applied Therapeutics, Inc.®'s alleged deceptive practices, and failure to meet basic compliance standards should receive justice and potential compensation, beginning with a free, private case review with our experienced legal team.

The Importance of Joining a Class Action

Class action lawsuits can provide an efficient mechanism to compensate injured victims, hold wrongdoers accountable, or affect how a company or an industry operates.  Class actions allow injured parties to come together and take on larger adversaries.  By leveraging the power of a group class members the class can match the resources of a corporate defendant and put the parties on equal footing.

If you have been adversely affected by corporate misconduct, you may join DiCello Levitt’s class action lawsuit and help hold the wrongdoers responsible for their alleged misconduct, potentially recover your financial losses, and contribute to enforcing higher ethical, governance, and compliance standards.  Your participation can make a difference.

To learn more about how to join the lawsuit and your potential eligibility, please contact DiCello Levitt.  DiCello Levitt is committed to representing the interests of all affected parties and pursuing justice in this significant case.

Find Out if You may be a Member
of the Class

Applied Therapeutics Inc® Class Action

Alexandru et al v. Applied Therapeutics, Inc. et al.

Applied Therapeutics Inc

NASDAQ: APLT

Class Period : 01/03/2024 - 12/02/2024

Lead Plaintiff Motion Deadline: 2/18/2025

Alleged Misstatements and Omissions
The lawsuit against Applied Therapeutics claims that the company misrepresented critical information about its lead drug candidate, govorestat, during its Phase III INSPIRE trial. Key allegations include:

  • Overstated Efficacy and Confidence: Applied Therapeutics emphasized positive clinical outcomes and confidence in its New Drug Application (NDA) to the FDA and its Marketing Authorization submission to the European Medicines Agency.
  • Concealed Data Issues: The company failed to disclose electronic data capture problems and a dosing error during the dose-escalation phase of the INSPIRE trial, which impacted trial reliability.

These misleading statements painted an overly optimistic picture of govorestat’s progress and potential, causing investors to purchase shares at inflated prices.

Effects on Stock Prices
The truth began to emerge through two key disclosures:

  • November 27, 2024: Applied Therapeutics announced it received a Complete Response Letter (CRL) from the FDA indicating the NDA could not be approved in its current form due to clinical application deficiencies. Following this news, the stock price dropped from $10.21 on November 26 to $8.57 on November 27 and to $2.03 on November 29, a total decline of over 80%.
  • December 2, 2024: After market hours, the company disclosed it received an FDA warning letter highlighting data capture issues and a dosing error. The stock price fell further, from $1.75 on December 2 to $1.29 on December 5.

These revelations caused significant financial losses for shareholders.

Legal Rights for Affected Shareholders
Shareholders who purchased Applied Therapeutics stock during the relevant period may have legal grounds to recover their losses. The lawsuit alleges that Applied Therapeutics violated securities laws by making false and misleading statements about the govorestat trial's progress.

By joining the class action, shareholders can:

  • Seek compensation for financial losses.
  • Hold Applied Therapeutics accountable for alleged misrepresentations.
  • Promote transparency and fairness in the company's disclosures.

You may qualify to participate in the case if you purchased Applied Therapeutics shares and suffered losses.

Take Action Today
Protect your rights and explore your legal options. Contact experienced securities fraud attorneys to ensure your claim is filed before legal deadlines.

Joining the Applied Therapeutics class action allows you to stand with other investors in demanding accountability and seeking fair compensation. Time is critical—act now to safeguard your legal rights.

iStock-1795167728

DiCello Levitt Fights to Protect Shareholder Rights  

At DiCello Levitt, we hold corporations accountable when they betray investor trust. With extensive experience in securities litigation, our legal team has the knowledge and resources to fight for your financial recovery. We understand the impact these losses can have on you and your family.  

Contact us today for a free, private case evaluation. Our attorneys will review your case, help you understand your legal options, and work tirelessly to seek the compensation you deserve. Let us advocate for your rights and ensure your voice is heard.  

Take the first step toward justice. Call us now or fill out our online form to get started.

All victims affected by Applied Therapeutics, Inc.®'s alleged deceptive practices, and failure to meet basic compliance standards should receive justice and potential compensation, beginning with a free, private case review with our experienced legal team.

The Importance of Joining a Class Action

Class action lawsuits can provide an efficient mechanism to compensate injured victims, hold wrongdoers accountable, or affect how a company or an industry operates.  Class actions allow injured parties to come together and take on larger adversaries.  By leveraging the power of a group class members the class can match the resources of a corporate defendant and put the parties on equal footing.

If you have been adversely affected by corporate misconduct, you may join DiCello Levitt’s class action lawsuit and help hold the wrongdoers responsible for their alleged misconduct, potentially recover your financial losses, and contribute to enforcing higher ethical, governance, and compliance standards.  Your participation can make a difference.

To learn more about how to join the lawsuit and your potential eligibility, please contact DiCello Levitt.  DiCello Levitt is committed to representing the interests of all affected parties and pursuing justice in this significant case.

100% Free & Secure Case Evaluations

Answer a few basic questions to get started

We'll ask specific questions to understand the situation, damage risk, and other vital information to help determine the next steps.

Receive a confidential evaluation

A qualified legal team led by a Financial Products Litigation attorney will consider the facts of your case.

Applied Therapeutics, Inc.® Investors may have grounds to pursue legal action and financial recovery of damages.

This website offers general information only and is not legal or investment advice. This advertisement is not associated with any government agency.

www.stockfraudclaim.com is the property of Shield Legal LLC. 5170 Badura Ave Las Vegas, NV 89118

Participating law firm: DiCello Levitt LLP, 10 North Dearborn Street Sixth Floor Chicago, IL 60602. For additional terms, disclaimers, and conditions, please visit https://dicellolevitt.com/privacy-policy/

This website is not part of the Facebook website or Facebook, Inc., and it is NOT endorsed by Facebook in any way. FACEBOOK is a trademark of Facebook, Inc.

ATTORNEY ADVERTISING. This Website does not provide investment, legal, or medical advice. Every case is evaluated on its facts and circumstances. Valuation depends on facts, injuries, jurisdiction, venue, witnesses, parties, and testimony, among other factors. No representation is made that the quality of legal services to be performed is greater than the quality of legal services performed by other lawyers. Stock Fraud Claim does not itself provide legal services. Cases will be referred to third-party attorneys and law firms.  Court costs and case expenses may be the responsibility of the client. Not available in all states. This advertisement is not intended as a testimonial, endorsement, or dramatization and does not constitute a guarantee, warranty, or prediction regarding the outcome of your legal matter, either expressed or implied. Anyone considering a lawyer should independently investigate the lawyer's credentials and ability, and not rely upon advertisements or self-proclaimed expertise. Only persons age 18 or older have permission to access our Service. Our Service does not address anyone under 13 ("Children").

NO ATTORNEY-CLIENT RELATIONSHIP. Use of this website, including sending or receiving information through it, does not establish an attorney-client relationship, nor is any non-passworded information considered privileged or confidential. No class has been certified.  Until a case is filed and a class is certified, you are not represented by counsel unless you retain one.  You may select counsel of your choice.  An attorney-client relationship with DiCello Levitt is established only by an express written agreement signed by DiCello Levitt to represent you.

Attorney Advertising.  Prior results do not guarantee a similar outcome.

Privacy Policy | Terms and Conditions | CCPA Privacy Notice | Do Not Sell My Info

©2024 Stock Fraud Claim. All Rights Reserved